The embolization coils market has seen considerable growth due to a variety of factors.
• The embolization coils market has grown strongly in recent years. It will increase from $1.44 billion in 2024 to $1.51 billion in 2025, at a CAGR of 5.0%.
This growth is attributed to the rising prevalence of neurovascular disorders, a growing elderly population, the increasing demand for minimally invasive procedures, improved healthcare infrastructure, and rising healthcare expenditures.
The embolization coils market is expected to maintain its strong growth trajectory in upcoming years.
• The embolization coils market is set to experience steady growth, reaching $1.81 billion by 2029 at a CAGR of 4.6%.
This growth is attributed to expanding applications in emerging markets, innovative embolization techniques, rising awareness of neurovascular disorders, and increasing R&D investments. Trends include personalized treatment approaches, AI integration, next-gen embolic materials, outpatient procedures, and a focus on patient-centric care.
The rising prevalence of chronic illnesses is expected to drive the embolization coils market. Chronic conditions like diabetes and hypertension are increasing due to aging populations and unhealthy lifestyles. Embolization coils are used to treat conditions such as coronary artery aneurysms by occluding abnormal connections. The American College of Cardiology projected in August 2022 that cardiovascular risk factors like diabetes would rise by 39.3%, further driving market demand.
The embolization coils market covered in this report is segmented –
1) By Type: Detachable Coil, Pushable Coil
2) By Material: Platinum, Platinum And Hydrogel, Platinum Tungsten Alloy
3) By Application: Neurology, Urology, Peripheral Vascular Disease, Oncology, Cardiology, Other Applications
4) By End-User: Hospitals, Ambulatory Center, Cardio Center, Other End-Users
Subsegments:
1) By Detachable Coil: Mechanical Detachable Coils, Electrothrombogenic Detachable Coils, Hydrogel-Coated Detachable Coils
2) By Pushable Coil: Bare Pushable Coils, Coiled Pushable Coils, Soft Pushable Coils
Companies in the embolization coils market are developing innovative products, such as fibered detachable coils, to improve the effectiveness of minimally invasive procedures. These coils are used to block or reduce blood flow in blood vessels. For example, in April 2022, Boston Scientific Corporation received FDA approval for its EMBOLD fibered detachable coil, designed to decrease blood flow in peripheral blood vessels during embolization procedures. This technique is used to treat various conditions, including hemorrhaging, aneurysms, and tumors.
Major companies operating in the embolization coils market are:
• Johnson & Johnson Services Inc.
• Abbott Laboratories Inc.
• Medtronic Plc
• Heraeus Holding
• Stryker Corporation
• Boston Scientific Corporation
• Terumo Corporation
• Kaneka Corporation
• Cook Medical LLC
• Integer Holdings Corporation
• MicroPort Scientific Corporation
• Penumbra Inc.
• Guerbet LLC
• Asahi Intecc Co. Ltd.
• MicroVention Inc.
• Balt USA LLC
• InNeuroCo Inc.
• Wallaby Medical Inc.
• Rapid Medical Ltd.
• Spartan Micro Inc.
• QXMedical LLC
• EmbolX Inc.
• Shape Memory Medical Inc.
• Blockade Medical LLC
• Achieva Medical Co.
North America was the largest region in the embolization coils market in 2023. Asia-Pacific is expected to be the fastest growing region in the forecast period. The regions covered in the embolization coils market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.